Skip to content
PaperFren

Which mitochondrial genes may drive IBD risk?

Open paper intelligence

Integrating methylation, expression, and protein QTLs via MR/colocalization flags PARK7 and ACADM as tier-1 mitochondrial genes for IBD/UC, with protective protein-level odds ratios.

Source

Multi-omic insight into the molecular networks of mitochondrial dysfunction in the pathogenesis of inflammatory bowel disease

Chen J, Ruan X, Sun Y, et al. · EBioMedicine · 2024

doi.org/10.1016/j.ebiom.2023.104934Read the full paper ↗120 citationscc by

Study at a glance

Design
Computational / modelling — Multi-omics Mendelian randomization + colocalization of mitochondrial QTLs vs IBD
N
N=2 · Two tier-1 mitochondrial genes (PARK7, ACADM); discovery IBDGC with UKB/FinnGen replication
Population
Genetic instruments from mQTL/eQTL/pQTL studies vs IBD/UC/CD GWAS
Outcome
Putative causal mitochondrial gene–IBD associations across omics layers

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Which mitochondrial genes may drive IBD risk?

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

Higher PARK7 protein linked to lower IBD risk (OR 0.36).

genetically predicted higher levels of PARK7 (OR 0.36, 95% CI 0.25–0.52)

HINT1 OR 0.47 for IBD; OR 0.26 for CD.

HINT1 (OR 0.47, 95% CI 0.30–0.74) were inversely associated with IBD risk
Read passages in the original paper

What they did

Used summary-data MR on mitochondrial gene methylation, expression, and protein QTLs against IBDGC (discovery) plus UK Biobank and FinnGen (replication), with colocalization to test shared causal variants.

What they found

PARK7 and ACADM had tier-1 multi-omic support for IBD/UC; PDK1 and FIS1 had weaker UC tiers. Higher genetically predicted PARK7 (OR 0.36) and HINT1 (OR 0.47) associated with lower IBD risk; higher HINT1 with lower CD (OR 0.26); higher ACADM/PDK1/FIS1 with lower UC.

The limits

What it doesn't show

MR associations are not clinical proof that modulating these proteins treats IBD; horizontal pleiotropy and cohort differences remain risks.

Key terms

Mendelian randomization
Uses genetic variants as instruments to infer causal effects.
Colocalization
Tests whether two traits share the same causal variant.
mQTL/eQTL/pQTL
Loci affecting methylation, expression, or protein levels.
PARK7
Mitochondrial-related gene with tier-1 IBD evidence here.
ACADM
Fatty-acid oxidation gene linked to UC across omics.

Flashcards

1 / 9

0 of 9 answers reviewed

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 5

Tier-1 genes highlighted were:

Common questions

Tier-1 genes?

PARK7 and ACADM.

PARK7 protein OR for IBD?

0.36 (95% CI 0.25–0.52).

Methods?

MR + colocalization across m/e/pQTLs.

Replication GWAS?

UK Biobank and FinnGen.

More on genetics